Nasdaq Ghrs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq ghrs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Ghrs Today - Breaking & Trending Today

Contrasting GH Research (NASDAQ:GHRS) & ORIC Pharmaceuticals (NASDAQ:ORIC)

GH Research (NASDAQ:GHRS – Get Free Report) and ORIC Pharmaceuticals (NASDAQ:ORIC – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, earnings and dividends. Earnings and Valuation This table compares GH […] ....

United States , South San Francisco , Gh Research Daily , Pfizer Inc , Gh Research , Pharmaceuticals Inc , Voronoi Inc , Given Gh Research , Mirati Therapeutics Inc , Get Free Report , Mirati Therapeutics , Nasdaq Ghrs , Stock Comparison , Stock Analysis ,

HC Wainwright Reiterates "Buy" Rating for GH Research (NASDAQ:GHRS)

HC Wainwright restated their buy rating on shares of GH Research (NASDAQ:GHRS – Free Report) in a research note released on Thursday morning, Benzinga reports. They currently have a $40.00 price objective on the stock. HC Wainwright also issued estimates for GH Research’s Q1 2024 earnings at ($0.20) EPS, Q2 2024 earnings at ($0.21) EPS, […] ....

Barclays Plc , Morgan Stanley , Gh Research Company Profile , Institutional Investors Weigh In On Gh Research , Millennium Management , Gh Research , Gh Research Daily , Gh Research Trading , Free Report , Get Free Report , Nasdaq Ghrs , Reiterated Rating , Hc Wainwright ,

GH Research Announces Grant of European Patent Covering all

DUBLIN, Ireland, Jan. 18, 2024 (GLOBE NEWSWIRE) GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming. ....

Theis Terwey , Julie Ryan , European Patent Office , Globe Newswire Gh Research , Exchange Commission , Gh Research , Nasdaq Ghrs , Gh Research Plc , Mental Health ,

GH Research PLC (NASDAQ:GHRS) Short Interest Update

GH Research PLC (NASDAQ:GHRS – Get Free Report) was the recipient of a large increase in short interest during the month of November. As of November 30th, there was short interest totalling 1,520,000 shares, an increase of 7.0% from the November 15th total of 1,420,000 shares. Approximately 5.5% of the shares of the company are […] ....

Barclays Plc , Gh Research Daily , Gh Research Stock Performance , Institutional Investors Weigh In On Gh Research , Gh Research , Millennium Management , Morgan Stanley , Gh Research Company Profile , Get Free Report , Nasdaq Ghrs ,

RA Capital Management L.P. Boosts Stock Position in GH Research PLC (NASDAQ:GHRS)

RA Capital Management L.P. raised its stake in shares of GH Research PLC (NASDAQ:GHRS – Free Report) by 0.1% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 5,587,333 shares of the company’s stock after acquiring an additional 6,172 shares during the […] ....

United States , Tower Research Capital , Securities Exchange Commission , Gh Research , America Corp , Gh Research Stock Performance , Gh Research Company Profile , Renaissance Technologies , Gh Research Daily , Free Report , Research Capital , Montreal Can , State Street Corp , Get Free Report , Nasdaq Ghrs , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,